Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Priya Bisht
Observed name:
Bisht, Priya
Institution:
National Institute of Pharmaceutical Education and Research
Observed institutions:
Indo Soviet Friendship College of Pharmacy,
National Institute of Pharmaceutical Education and Research
ORCID:
0009-0005-0319-1310
Observed ORCID:
0009-0005-0319-1310
OpenAlex ID:
A5100600987
Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations
2024
·
Rupali Kohal
, Priya Bisht
, et al.
·
Bioorganic Chemistry
·
40
Design and synthesis of novel 3,7-dihydro-1H-purine-2,6-diones as DPP-4 inhibitors: An in silico, in vitro and in vivo approach
2024
·
Priya Bisht
, Arka Bhattacharya
, et al.
·
European Journal of Medicinal Chemistry
·
8
Designing of xanthine-based DPP-4 inhibitors: a structure-guided alignment dependent Multifacet 3D-QSAR modeling, and molecular dynamics simulation study
2024
·
Priya Bisht
, Priyadarshi Gautam
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
7
Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agents
2025
·
Shiv Kumar
, Rupali Kohal
, et al.
·
Future Medicinal Chemistry
·
6
Tirzepatide: A First-in-class Twincretin for the Management of Type 2 Diabetes
2023
·
Shalini Jaswal
, Priya Bisht
, et al.
·
Letters in Drug Design & Discovery
·
5
PDF
Unveiling the medicinal diversity of benzoic acid containing molecules: Insights on druggable targets for type 2 diabetes mellitus
2025
·
Kajal Rani
, Preety Kumari
, et al.
·
Bioorganic & Medicinal Chemistry
·
4
Exploring the pharmacological versatility of triazolopyrazine: A multi-target scaffold for drug development
2025
·
Debarshi Mondal
, Priya Bisht
, et al.
·
Future Medicinal Chemistry
·
3
PDF
Mechanistic and metabolic exploration of neohesperidin against lung cancer cell lines through ROS-mediated mitochondrial apoptosis: An in-silico and in-vitro approach
2025
·
Ruchi Pandey
, Khushboo Choudhary
, et al.
·
Toxicology and Applied Pharmacology
·
3
A comprehension on structure guided alignment dependent 3D-QSAR modelling, and molecular dynamics simulation on 2,4-thiazolidinediones as aldose reductase inhibitors for the management of diabetic complications
2023
·
Priyadarshi Gautam
, Priya Bisht
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
3
Pyrimidine‐2,4‐dione‐Based DPP‐4 Inhibitors: A Structure‐Guided Multifaced 3D‐QSAR and Molecular Dynamics Studies
2025
·
Rupali Kohal
, Preety Kumari
, et al.
·
ChemistrySelect
·
1
NRF2 activation by myrcene restores redox balance and metabolic homeostasis in a mouse model of type 2 diabetes
2026
·
Ruchi Pandey
, Adarsh Kumar Ray
, et al.
·
3 Biotech
In silico De Novo Discovery of Novel Target-specific Drug-like Bidentate Inhibitors of PTP 1B
2023
·
Shalini Jaswal
, Kankan Roy
, et al.
·
Letters in Drug Design & Discovery
De novo designing of novel drug-like inhibitors of aldose reductase
2023
·
Priyadarshi Gautam
, Priya Bisht
, et al.
·
Pharmaspire
PDF
In silico studies on Urtica dioica as aldose reductase inhibitors
2023
·
Megha Goswami
, Priya Bisht
, et al.
·
Pharmaspire
PDF
Show more works
View as search
Works count:
17
Citation count:
80
H-index:
5
I10-index:
1
Year
Topic
Type